Doctor Huihua Li
Pfizer, New York (United States of America)
Estimating treatment effect of tafamidis on hospitalisation in NYHA class III ATTR-CM patients in the presence of death using principal stratification
Event: ESC Congress 2021 - The Digital Experience
Topic: Epidemiology, Prognosis, Outcome
Session: Chronic heart failure e-posters
ESC 365 is supported by
